- Email: [email protected]
Definitive radiotherapy for vulvar carcinoma
TESTICULAR CANCER ACCORDING TO AGE
M. A. Batata, M.D.: W. F. Whitmore, Jr., M.D., B. S. Hilaris, M.D., A. Unal, M.D., F. Chu, M.D., H. Grabstald, M.D., and R. Golbey, M.D. Department of Radiation Therapy, Urologic Service, Department of Surgery, and Solid Tumor Service, Department of Medicine, Memorial 10021 Sloan-Kettering Cancer Center, New York, New York
Nine-hundred and forty-one patients with a testicular cancer treated mainly at the Memorial Sloan-Kettering Cancer Center from 1940 to 1974, were divided into four groups according to age. Group 1 of 125 younger patients with ages ranging from 1 to 20 years. Group 2 of 276 young adults 21 to 30 years old. Group 3 of 437 were in the middle age 31 to 49 years. Group 4 of 103 older patients with ages 50 to 80 years. Clinical presentation, pathological findings, methods of treatment, especially radiation therapy, survival according to tumor stage and histological type, and patterns of recurrence, will be discussed in the four groups.
(53)
DEFINITIVE RADIOTHERAPY
FOR VULVAR CARCINOMA
J. Bosworth, M.D.$ P. Ager, M.D., M. Moukhtar, M.D., S. Romney, M.D., and N. A. Ghossein, M.D. Division of Radiotherapy (JB,PA,NAG) and Department of Obstetrics and Gynecology (MM,SR), Albert Einstein College of Medicine, Bronx, NY Carcinoma of the vulva has classically been treated with radical surgery Radiotherapy has not been considered as a curative approach because the tumor has been thought to be "radio-resistant". Three patients deemed to be,medically inoperable were irradiated to the primary and nodal regions using a combination of external therapy (Cobalt-60) and interstitial implantation. Patients initially received 3500-4000 rad external therapy in 3% - 4 weeks to the primary and 5000 rad to the inguinal nodes in 5 weeks. This was followed by a removable iridium implant to the primary for another 4000 rad (average dose). All patients tolerated the treatment well and are free of disease for 13-24 months. The implantation technique and rationale for this conservative therapy will be discussed.
STAGE III ENDOMETRIAL CARCINOMA: (54) RESULTS OF TREATMENT WITH COMBINED SURGERY AND IRRADIATION James E. Bruckman, M.D., William D. Bloomer, M.D.*, Abraham Marck, M.D., Robert L. Ehrmann, M.D., and Robert C. Knapp, M.D. From the Joint Center for Radiation Therapy and the Departments of Radiation Therapy, Pathology, Obstetrics and Gynecology, Harvard Medical School, Boston, Massachusetts 02115
61
M. A. Batata, M.D.: W. F. Whitmore, Jr., M.D., B. S. Hilaris, M.D., A. Unal, M.D., F. Chu, M.D., H. Grabstald, M.D., and R. Golbey, M.D. Department of Radiation Therapy, Urologic Service, Department of Surgery, and Solid Tumor Service, Department of Medicine, Memorial 10021 Sloan-Kettering Cancer Center, New York, New York
Nine-hundred and forty-one patients with a testicular cancer treated mainly at the Memorial Sloan-Kettering Cancer Center from 1940 to 1974, were divided into four groups according to age. Group 1 of 125 younger patients with ages ranging from 1 to 20 years. Group 2 of 276 young adults 21 to 30 years old. Group 3 of 437 were in the middle age 31 to 49 years. Group 4 of 103 older patients with ages 50 to 80 years. Clinical presentation, pathological findings, methods of treatment, especially radiation therapy, survival according to tumor stage and histological type, and patterns of recurrence, will be discussed in the four groups.
(53)
DEFINITIVE RADIOTHERAPY
FOR VULVAR CARCINOMA
J. Bosworth, M.D.$ P. Ager, M.D., M. Moukhtar, M.D., S. Romney, M.D., and N. A. Ghossein, M.D. Division of Radiotherapy (JB,PA,NAG) and Department of Obstetrics and Gynecology (MM,SR), Albert Einstein College of Medicine, Bronx, NY Carcinoma of the vulva has classically been treated with radical surgery Radiotherapy has not been considered as a curative approach because the tumor has been thought to be "radio-resistant". Three patients deemed to be,medically inoperable were irradiated to the primary and nodal regions using a combination of external therapy (Cobalt-60) and interstitial implantation. Patients initially received 3500-4000 rad external therapy in 3% - 4 weeks to the primary and 5000 rad to the inguinal nodes in 5 weeks. This was followed by a removable iridium implant to the primary for another 4000 rad (average dose). All patients tolerated the treatment well and are free of disease for 13-24 months. The implantation technique and rationale for this conservative therapy will be discussed.
STAGE III ENDOMETRIAL CARCINOMA: (54) RESULTS OF TREATMENT WITH COMBINED SURGERY AND IRRADIATION James E. Bruckman, M.D., William D. Bloomer, M.D.*, Abraham Marck, M.D., Robert L. Ehrmann, M.D., and Robert C. Knapp, M.D. From the Joint Center for Radiation Therapy and the Departments of Radiation Therapy, Pathology, Obstetrics and Gynecology, Harvard Medical School, Boston, Massachusetts 02115
61